z-logo
open-access-imgOpen Access

Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods

Author(s) -
Hongmei Zhang,
Xi-Yang Liu,
Yuzhang Liu,
Lina Liu,
Quande Lin,
Yongping Song,
Baijun Fang
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s218979
Subject(s) - bortezomib , medicine , multiple myeloma , adverse effect , subcutaneous injection , toxicity , surgery , gastroenterology , urology
This study aims to compare the efficacy and adverse reactions of bortezomib for treating newly diagnosed multiple myeloma (MM) through two different administration methods: intravenous (IV) injection and subcutaneous (SC) injection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here